Literature DB >> 8256228

Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.

R F Taylor1, M E Hodson, T L Pitt.   

Abstract

BACKGROUND: Pseudomonas aeruginosa has been located in the endobronchiolar spaces of patients with cystic fibrosis where nutrients may be limited. In these sites it is thought that adaptation of the pathogen might occur and growth factors, present in relative excess, may thus promote survival of the organism. Auxotrophy of pulmonary isolates of P aeruginosa has previously been shown to be a feature of cystic fibrosis and chronic lung sepsis; auxotrophic isolates have additional nutritional requirements to the prototrophic "wild types" of the species. A study was therefore carried out to determine whether the proportion of auxotrophs differs between stable and acutely ill patients, or correlates with the extent of underlying disease.
METHODS: Sputum samples were cultured for P aeruginosa and tested for auxotrophy by spreading serial dilutions of homogenised sputum on to a minimal medium which supports only prototrophs, and a complete medium which supports both nutritional types. The proportion of auxotrophs to prototrophs was determined and growth factors of confirmed auxotrophs were identified.
RESULTS: Thirty two (86%) of 37 adults with cystic fibrosis infected with P aeruginosa harboured auxotrophs; methionine dependent mutants were isolated from seven of 16 patients tested (44%). More than 50% of the total number of colonies were auxotrophic in 19 of 26 samples (73%) from patients with acute exacerbations and in only six of 15 samples (40%) from clinically stable patients. In four patients from whom samples in both the acute and stable states were available, the proportion of auxotrophs fell in the sample taken when stable. Auxotrophs predominated in all samples from 11 of those patients with very severe underlying lung disease, in contrast to 13 of 30 samples from patients with less severe disease. There was no association between the percentage of auxotrophs and the presence of other respiratory pathogens.
CONCLUSIONS: The majority of adults with cystic fibrosis infected with P aeruginosa harbour auxotrophs in the sputum. A significant proportion of acutely ill patients and those with severe underlying disease have a preponderance of auxotrophs in the sputum compared with stable patients and those with less severe disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256228      PMCID: PMC464811          DOI: 10.1136/thx.48.10.1002

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  STUDIES ON PULMONARY SECRETIONS. I. THE OVER-ALL CHEMICAL COMPOSITION OF PULMONARY SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS, BRONCHIECTASIS, AND LARYNGECTOMY.

Authors:  L W MATTHEWS; S SPECTOR; J LEMM; J L POTTER
Journal:  Am Rev Respir Dis       Date:  1963-08

2.  Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.

Authors:  D P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

3.  The identification of pseudomonads and related bacteria in a clinical laboratory.

Authors:  A King; I Phillips
Journal:  J Med Microbiol       Date:  1978-05       Impact factor: 2.472

4.  Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  R F Taylor; M E Hodson; T L Pitt
Journal:  FEMS Microbiol Lett       Date:  1992-05-01       Impact factor: 2.742

Review 5.  Strategies and perspectives in treatment of respiratory infections.

Authors:  H J Neijens
Journal:  Acta Paediatr Scand Suppl       Date:  1989

6.  Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration.

Authors:  R S Baltimore; C D Christie; G J Smith
Journal:  Am Rev Respir Dis       Date:  1989-12

7.  Synergistic activity of 5-trifluoromethylthioribose and inhibitors of methionine synthesis against Klebsiella pneumoniae.

Authors:  P A Tower; L L Johnson; A J Ferro; J H Fitchen; M K Riscoe
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

Review 8.  Cystic fibrosis. 2. Lung injury in cystic fibrosis.

Authors:  J S Elborn; D J Shale
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

9.  Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; D F Welch; M J Muszynski; K R Wait
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

Review 10.  Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.

Authors:  T L Pitt
Journal:  J R Soc Med       Date:  1986       Impact factor: 18.000

View more
  14 in total

1.  Genome macrorestriction analysis of sequential Pseudomonas aeruginosa isolates from bronchiectasis patients without cystic fibrosis.

Authors:  S W Hla; K P Hui; W C Tan; B Ho
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL.

Authors:  D De Vos; A Lim; J P Pirnay; M Struelens; C Vandenvelde; L Duinslaeger; A Vanderkelen; P Cornelis
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease.

Authors:  S R Thomas; A Ray; M E Hodson; T L Pitt
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

5.  Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients.

Authors:  A L Barth; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

6.  Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis.

Authors:  A L Barth; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

7.  Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients.

Authors:  Xuan Qin; Danielle M Zerr; Michael A McNutt; Jessica E Berry; Jane L Burns; Raj P Kapur
Journal:  Antimicrob Agents Chemother       Date:  2012-09-10       Impact factor: 5.191

8.  Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients.

Authors:  Pieter Deschaght; Petra Schelstraete; Guido Lopes dos Santos Santiago; Leen Van Simaey; Filomeen Haerynck; Sabine Van Daele; Elke De Wachter; Anne Malfroot; Patrick Lebecque; Christiane Knoop; Georges Casimir; Hedwige Boboli; Frédéric Pierart; Kristine Desager; Mario Vaneechoutte; Frans De Baets
Journal:  BMC Microbiol       Date:  2010-09-24       Impact factor: 3.605

9.  Clinical application of a rapid microbiological test based on capillary zone electrophoresis to assess local skin infection.

Authors:  Jacek Szeliga; Marek Jackowski; Ewa Kłodzińska; Bogusław Buszewski; Wojciech Kupczyk
Journal:  BMC Res Notes       Date:  2011-10-30

10.  Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients.

Authors:  Pieter Deschaght; Thierry De Baere; Leen Van Simaey; Sabine Van Daele; Frans De Baets; Daniel De Vos; Jean-Paul Pirnay; Mario Vaneechoutte
Journal:  BMC Microbiol       Date:  2009-11-29       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.